Cohera Medical put a bow on the clinical trial for its Sylys surgical sealant, saying that it confirmed the safety of the leakage-preventing product.
Sylys is a synthetic sealant "specifically designed to significantly reduce anastomotic leakage in intestinal anastomosis procedures," used in conjunction with standard anastomotic closure techniques. Sylys supports anastomosis during the 1st few days of healing, when leaks are most likely to occur.
"Sylys enhances standard closure techniques, advancing the healing process and reducing post-operative complications," president & CEO Patrick Daly said in prepared remarks. "
With the completion of this study, we are a step closer to providing patients with the best opportunity for a successful outcome following intestinal anastomosis procedures."
The Pittsburgh-based medical device company recently finished its pre-market approval application for its TissuGlu surgical adhesive. The company completed the last module, comprised of data from the Pittsburgh based-company’s ‘No Drain’ study, in November.